Cardiovascular disease - DiabetesontheNet

Preventing death, CVD and renal complications in type 1 patients: The triple shield

Could non-physician clinical care have a role in the UK?

Semaglutide and SUSTAIN-6: Another step towards the holy grail of type 2 diabetes management?

Screening for diabetes and cardiovascular disease outcomes in people of South Asian ethnicity in Bolton

Statins, safety studies and sharing good practice

The edict from DCCT/EDIC: Reducing the risk of cardiovascular disease in people with type 1 diabetes

EMPA-REG: Empagliflozin’s benefits were not driven by participants with pre-existing heart failure

Don’t Just Screen – Intervene: Protecting the cardiometabolic health of people with severe mental illness

Unit 2 – Comorbidities and complications: Managing dyslipidaemia in the context of diabetes

Following recent NICE guidance, should healthcare professionals stop aspirin in people with diabetes without CVD?

Metabolic surgery

Unit 2 – Comorbidities and complications: Managing hypertension in type 2 diabetes

Diabetes in stroke: An overview

Time to stress those New Year’s Resolutions again!

RAAS blockers: Best taken at bedtime

Keeping abreast of the latest diabetes research: Glycaemic control

Keeping abreast of the latest diabetes research: HbA1c screening, older people and empagliflozin

Cardiovascular outcome trials in type 2 diabetes – 2015